| Pan-cancer analysis of whole genomes Nature 578 (7793), 82-93, 2020 | 1666* | 2020 |
| Whole-genome landscapes of major melanoma subtypes NK Hayward, JS Wilmott, N Waddell, PA Johansson, MA Field, K Nones, ... Nature 545 (7653), 175-180, 2017 | 1261 | 2017 |
| PD‐L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti‐PD‐1/PD‐L 1 clinical trials J Madore, RE Vilain, AM Menzies, H Kakavand, JS Wilmott, J Hyman, ... Pigment cell & melanoma research 28 (3), 245-253, 2015 | 436 | 2015 |
| PD-L1 expression is a favorable prognostic factor in early stage non-small cell carcinoma WA Cooper, T Tran, RE Vilain, J Madore, CI Selinger, M Kohonen-Corish, ... Lung cancer 89 (2), 181-188, 2015 | 319 | 2015 |
| Programmed death ligand 1 expression in triple‐negative breast cancer is associated with tumour‐infiltrating lymphocytes and improved outcome RK Beckers, CI Selinger, R Vilain, J Madore, JS Wilmott, K Harvey, ... Histopathology 69 (1), 25-34, 2016 | 240 | 2016 |
| Immunohistochemistry for SDHB divides gastrointestinal stromal tumors (GISTs) into 2 distinct types AJ Gill, A Chou, R Vilain, A Clarkson, M Lui, R Jin, V Tobias, J Samra, ... The American journal of surgical pathology 34 (5), 636-644, 2010 | 240 | 2010 |
| Dynamic changes in PD-L1 expression and immune infiltrates early during treatment predict response to PD-1 blockade in melanoma RE Vilain, AM Menzies, JS Wilmott, H Kakavand, J Madore, A Guminski, ... Clinical Cancer Research 23 (17), 5024-5033, 2017 | 239 | 2017 |
| PD-L1 expression and tumor-infiltrating lymphocytes define different subsets of MAPK inhibitor–treated melanoma patients H Kakavand, JS Wilmott, AM Menzies, R Vilain, LE Haydu, JH Yearley, ... Clinical Cancer Research 21 (14), 3140-3148, 2015 | 146 | 2015 |
| Loss of SDHA expression identifies SDHA mutations in succinate dehydrogenase–deficient gastrointestinal stromal tumors T Dwight, DE Benn, A Clarkson, R Vilain, L Lipton, BG Robinson, ... The American journal of surgical pathology 37 (2), 226-233, 2013 | 123 | 2013 |
| PD-L1 negative status is associated with lower mutation burden, differential expression of immune-related genes, and worse survival in stage III melanoma J Madore, D Strbenac, R Vilain, AM Menzies, JYH Yang, JF Thompson, ... Clinical Cancer Research 22 (15), 3915-3923, 2016 | 110 | 2016 |
| Tumor PD-L1 expression, immune cell correlates and PD-1+ lymphocytes in sentinel lymph node melanoma metastases H Kakavand, RE Vilain, JS Wilmott, H Burke, JH Yearley, JF Thompson, ... Modern Pathology 28 (12), 1535-1544, 2015 | 92 | 2015 |
| “Pediatric-type” gastrointestinal stromal tumors are SDHB negative (“type 2”) GISTs AJ Gill, A Chou, RE Vilain, RJ Clifton-Bligh The American journal of surgical pathology 35 (8), 1245-1247, 2011 | 60 | 2011 |
| PD-L1 expression in tonsillar cancer is associated with human papillomavirus positivity and improved survival: implications for anti-PD1 clinical trials AM Hong, RE Vilain, S Romanes, J Yang, E Smith, D Jones, RA Scolyer, ... Oncotarget 7 (47), 77010, 2016 | 57 | 2016 |
| Primary and metastatic cutaneous melanomas express ALK through alternative transcriptional initiation KJ Busam, RE Vilain, T Lum, JA Busam, TJ Hollmann, RPM Saw, DC Coit, ... The American journal of surgical pathology 40 (6), 786-795, 2016 | 52 | 2016 |
| Repair of UVB-induced DNA damage is reduced in melanoma due to low XPC and global genome repair T Budden, RJ Davey, RE Vilain, KA Ashton, SG Braye, NJ Beveridge, ... Oncotarget 7 (38), 60940, 2016 | 43 | 2016 |
| Elevated postmortem vitreous sodium and chloride levels distinguish saltwater drowning (SWD) deaths from immersion deaths not related to drowning but recovered from saltwater … AD Cala, R Vilain, R Tse The American Journal of Forensic Medicine and Pathology 34 (2), 133-138, 2013 | 35 | 2013 |
| Histological pattern of Merkel cell carcinoma sentinel lymph node metastasis improves stratification of Stage III patients JS Ko, VG Prieto, PJ Elson, RE Vilain, MP Pulitzer, RA Scolyer, ... Modern Pathology 29 (2), 122-130, 2016 | 31 | 2016 |
| Monitoring patient response to pembrolizumab with peripheral blood exhaustion marker profiles M Graves, G CelliMarchett, B Van Zyl, D Tang, RE Vilain, ... Frontiers in Medicine 6, 113, 2019 | 19 | 2019 |
| Programmed death-ligand 1 expression in a large cohort of pediatric patients with solid tumor and association with clinicopathologic features in neuroblastoma F Saletta, RE Vilain, AK Gupta, S Nagabushan, A Yuksel, D Catchpoole, ... JCO Precision Oncology 1, 1-12, 2017 | 19 | 2017 |
| Detailed pathological examination of completion node dissection specimens and outcome in melanoma patients with minimal (< 0.1 mm) sentinel lymph node metastases LHJ Holtkamp, S Wang, JS Wilmott, J Madore, R Vilain, JF Thompson, ... Annals of surgical oncology 22, 2972-2977, 2015 | 19 | 2015 |
Richard A ScolyerMelanoma Institute Australia, The University of Sydney, Royal Prince Alfred HospitalVerified email at sswahs.nsw.gov.au
